Gay dating cancer
Male Gender Based Eligibility: Yes Gender Eligibility Description: Male bodied persons at risk of prostate cancer Accepts Healthy Volunteers: No Criteria Inclusion Criteria:. Hide glossary Glossary Study record managers: Search for terms x. Save this study.
Warning You have reached the maximum number of saved studies Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. Federal Government.
When to talk about cancer
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. NCT Recruitment Status: Recruiting First Posted: November 17, Last Update Posted: January 23, See Contacts and Locations. Study Description. Development and evaluation of an online intervention addressing sexual functioning in MSM after prostate cancer treatment.
MedlinePlus related topics: FDA Resources. Arms and Interventions. Intervention Evaluation Control Group Surveys at 3 month intervals. We will evaluate the effects of an educational, tailored, online rehabilitation program addressing sexual and urinary outcomes after treatment by surveying at 3 month intervals.
Multi-component, structured, biopsychosocial, online interactive program to address the sexual and urinary effects of prostate cancer treatment. Outcome Measures. Primary Outcome Measures: Eligibility Criteria.source site
National LGBT Cancer Network Gay Men and Cancer
Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. No Criteria. Inclusion Criteria: Gay or Bisexual Men, defined as a biological adult male, who by self-report, has had sex with a man.
Treated for prostate cancer, defined as i having been diagnosed with prostate cancer and measured by being able to report a Prostate- Specific Antigen and Gleason score; and ii treated by radical prostatectomy, radiation or systemically. This is measured by a screener item s asking the enrollee to describe their current function last 4 weeks and validated by nurse interview. Living in the US including territories as measured by valid US zip code. A unique, validated individual, as measured by our published de-duplication and cross-validation protocols, and confirmed by video or phone interview.
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
Exclusion Criteria: However, studies have shown that gay and bisexual men are more negatively impacted by the side effects of prostate cancer than straight men are. The impact on intimacy for gay and bisexual men is particularly profound. Talking with your partner about erectile dysfunction and utilizing the resources available through Malecare may help you navigate these difficulties. Although prostate cancer is often described as a male cancer including on this website , the reality is that anyone who was born with a prostate can develop prostate cancer.
If you have a doctor you trust, that is the best person to talk to about your specific risk. Prostate Cancer Canada also has a very detailed and well-cited page about the effects of gender-confirming surgery and transitional hormones on prostate cancer risk, screening, and diagnosis for trans women.
It can be emotionally difficult to have a male-associated cancer as someone who does not identify as male, especially since most prostate cancer support groups and resources are targeted at men. Consider building a support network of friends, family, or counselors with whom you feel comfortable discussing your prostate cancer diagnosis. Malecare can also connect you with social workers who can help you.
The LGBT Community and Prostate Cancer
Additionally, Prostate Cancer UK is trialing an online support group for trans women, and you can find more information here. Although the ZERO website uses male terms and pronouns, they are not meant to exclude transgender women or gender-nonconforming individuals. If you have been diagnosed with prostate cancer, take a look at the rest of our Learn section to gather more information about the disease.
Having a doctor with whom you can be open about your sexual orientation or gender identity is important. Guideline on the Pharmacologic Management of Premature Ejaculation. Curr Urol Rep. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol. Orgasm associated incontinence climacturia following radical pelvic surgery: Rates of occurrence and predictors. Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function.
Support Care Cancer. Clifford D. Caring for sexuality in loss. In Wells, D. Caring for Sexuality in Health and Illness. Philadelphia, PA; Churchill Livingstone. Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study.
The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. Katz A. The Sounds of Silence: Sexuality information for cancer patients.
J Clin Onc. Knight D. Health care screening for men who have sex with men. Am Fam Physician. Climacturia following radical prostatectomy: Organ-preserving surgery for penile carcinoma. Adv Urol. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. National Cancer Institute. Sexuality and Fertility Problems Men. The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer.
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst.